As of Feb 18, 2025, Fresenius Medical Care AG & Co. KGaA Intrinsic Value is $50.9. This suggests it may be undervalued by 115.2% compared to its current price of around $23.6.
As of Feb 18, 2025, Fresenius Medical Care AG & Co. KGaA's Discounted Cash Flow (DCF) valuation estimates its share price at $66.3. This suggests it may be overvalued by 180.6% to its current price of around $23.6, using a discount rate of 4.9% and terminal growth rate of 3.0%.
Fresenius Medical Care AG & Co. KGaA is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $50.9, compared to a market price of around $23.6. This suggests a potential undervaluation of 115.2%.